Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 611.2 USD 3.15% Market Closed
Market Cap: 229.6B USD

TMO's latest stock split occurred on Jun 6, 1996

The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.

The adjusted shares began trading on Jun 6, 1996. This was TMO's 6th stock split, following the previous one in May 25, 1995.

Last Splits:
Jun 6, 1996
3-for-2
May 25, 1995
3-for-2
Oct 29, 1993
3-for-2
Nov 3, 1986
3-for-2
Sep 17, 1985
3-for-2
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
Last Splits:
Jun 6, 1996
3-for-2
May 25, 1995
3-for-2
Oct 29, 1993
3-for-2
Nov 3, 1986
3-for-2
Sep 17, 1985
3-for-2

Thermo Fisher Scientific Inc
Stock Splits History

TMO Stock Splits Timeline
Jun 6, 1996
Jun 6, 1996
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
May 25, 1995
May 25, 1995
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
Oct 29, 1993
Oct 29, 1993
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
Nov 3, 1986
Nov 3, 1986
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
Sep 17, 1985
Sep 17, 1985
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After
Jan 4, 1984
Jan 4, 1984
Split 3-for-2
x1.5
Pre-Split Price
N/A
Post-Split Price
23.9018
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.46 8.46 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Dec 30, 2025
Adicet Bio Inc
NASDAQ:ACET
1-for-16
/16
0.4921 0.4921 USD 7.93 7.93 USD
Load More

Thermo Fisher Scientific Inc
Glance View

Thermo Fisher Scientific Inc. stands as a towering entity in the life sciences industry, intricately weaving together science, technology, and business to drive scientific progress and innovation. Founded through a merger of Thermo Electron and Fisher Scientific in 2006, the company has grown exponentially to become a formidable partner for researchers, academicians, and clinicians worldwide. Its business model is built around a broad portfolio of offerings, including laboratory instruments, analytical tools, and consumables, which are crucial for research and quality control. By emphasizing research and development, Thermo Fisher has consistently advanced its technologies, ensuring that its solutions remain indispensable to ventures in pharmaceuticals, biotechnology, and diagnostics. The strategic acquisition of complementary businesses has been a key facet of Thermo Fisher’s growth, fortifying its position across various scientific fields. In essence, the company thrives on understanding the increasingly complex demands of the scientific community. It generates revenue by capitalizing on its diverse product lineup, subscription-based services, and personalized solutions that cater to specific client needs—ranging from equipment used to perform intricate genomic sequencing to reagents required for advanced laboratory experiments. Thus, Thermo Fisher sustains its financial health through a combination of one-time sales and recurring revenue streams, a strategy that not only reflects its adaptability but also ensures long-term profitability and market leadership in the ever-evolving landscape of scientific research.

TMO Intrinsic Value
527.97 USD
Overvaluation 14%
Intrinsic Value
Price
Back to Top